Evaluation of adverse effects with COVID-19 vaccination in Pakistan

被引:24
作者
Abbas, Sana [1 ]
Abbas, Beenish [3 ]
Amir, Sidra [3 ]
Wajahat, Mehreen [2 ]
机构
[1] Gwadar Dev Author Hosp, Gwadar, Pakistan
[2] Avicenna Med & Dent Coll, Lahore, Pakistan
[3] Fdn Univ, Islamabad, Pakistan
关键词
Covid-19; Vaccine; Adverse effects;
D O I
10.12669/pjms.37.7.4522
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Vaccinations work with different mechanisms to offer protection against disease; however, process of immunity building can cause symptoms. Therefore, this study aimed to determine the immediate side effects of COVID-19 vaccination in the Pakistani Population. Methods: This cross-sectional analytical study was conducted at Foundation University College of Dentistry, Islamabad from February to April 2021. 0.5 mL per dose of the Covid-19 vaccine was administered to the candidates. These 205 candidates receiving vaccination were then interviewed investigating the adverse effects of the vaccine. Post-vaccination side effects were compared among categorical groups using the Chi-Square test, whereas post-vaccination side effects were compared with age using independent samples T-test. A p-value of <= 0.05 was statistically significant. Results: Among post-vaccination side effects, fever was reported by 69 participants, while 56 of 205 reported soreness, redness, and swelling at the injection site. It was reported by 42/205 participants to have felt chills and rigor, whereas gastrointestinal disturbance and flu-like symptoms were reported in 55/205 and 28/205 participants, respectively. Younger participants were more likely to develop gastrointestinal disturbance and flu-like symptoms following vaccination as compared to older participants. Conclusion: Malaise, headache, and fever were observed to be the most common side effects of the vaccine, moreover there was a linear relationship between manifestations of adverse effects and history of comorbidities.
引用
收藏
页码:1959 / 1964
页数:6
相关论文
共 18 条
[1]   Rituximab-related viral infections in lymphoma patients [J].
Aksoy, Sercan ;
Harputluoglu, Hakan ;
Kilickap, Saadettin ;
Dede, Didem Sener ;
Dizdar, Omer ;
Altundag, Kadri ;
Barista, Ibrahim .
LEUKEMIA & LYMPHOMA, 2007, 48 (07) :1307-1312
[2]  
Bhopal S, 2020, SSRN NATURE IMMUNE R
[3]   BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting [J].
Dagan, Noa ;
Barda, Noam ;
Kepten, Eldad ;
Miron, Oren ;
Perchik, Shay ;
Katz, Mark A. ;
Hernan, Miguel A. ;
Lipsitch, Marc ;
Reis, Ben ;
Balicer, Ran D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (15) :1412-1423
[4]   Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial [J].
Folegatti, Pedro M. ;
Ewer, Katie J. ;
Aley, Parvinder K. ;
Angus, Brian ;
Becker, Stephan ;
Belij-Rammerstorfer, Sandra ;
Bellamy, Duncan ;
Bibi, Sagida ;
Bittaye, Mustapha ;
Clutterbuck, Elizabeth A. ;
Dold, Christina ;
Faust, Saul N. ;
Finn, Adam ;
Flaxman, Amy L. ;
Hallis, Bassam ;
Heath, Paul ;
Jenkin, Daniel ;
Lazarus, Rajeka ;
Makinson, Rebecca ;
Minassian, Angela M. ;
Pollock, Katrina M. ;
Ramasamy, Maheshi ;
Robinson, Hannah ;
Snape, Matthew ;
Tarrant, Richard ;
Voysey, Merryn ;
Green, Catherine ;
Douglas, Alexander D. ;
Hill, Adrian V. S. ;
Lambe, Teresa ;
Gilbert, Sarah C. ;
Pollard, Andrew J. .
LANCET, 2020, 396 (10249) :467-478
[5]  
Food and Drug Administration, 2020, Vitro Drug Interaction Studies: Cytochrome P450 Enzymeand Transporter-Mediated Drug Interactions Guidance for Industry, P1
[6]   COVID-19 vaccines: where we stand and challenges ahead [J].
Forni, Guido ;
Mantovani, Alberto .
CELL DEATH AND DIFFERENTIATION, 2021, 28 (02) :626-639
[7]  
Johnson M, 2020, WHO Target Product Profiles for COVID-19 Vaccines, V10, P1
[8]   Threat of COVID-19 Vaccine Hesitancy in Pakistan: The Need for Measures to Neutralize Misleading Narratives [J].
Khan, Yusra Habib ;
Mallhi, Tauqeer Hussain ;
Alotaibi, Nasser Hadal ;
Alzarea, Abdulaziz Ibrahim ;
Alanazi, Abdullah Salah ;
Tanveer, Nida ;
Hashmi, Furqan Khurshid .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2020, 103 (02) :603-604
[9]   SARS-CoV-2 vaccines in development [J].
Krammer, Florian .
NATURE, 2020, 586 (7830) :516-527
[10]   A global survey of potential acceptance of a COVID-19 vaccine [J].
Lazarus, Jeffrey V. ;
Ratzan, Scott C. ;
Palayew, Adam ;
Gostin, Lawrence O. ;
Larson, Heidi J. ;
Rabin, Kenneth ;
Kimball, Spencer ;
El-Mohandes, Ayman .
NATURE MEDICINE, 2021, 27 (02) :225-+